Darren G. Woodside, PhD

Darren Woodside, Ph.D., is the Vice President for Research and Director of the Flow Cytometry and Imaging Core at the Texas Heart Institute. Show full bio

Dr. Woodside’s research centers around the role that cell adhesion plays in cardiovascular and autoimmune diseases, and the development of novel means to identify and treat these diseases. Prior to assuming the position of Vice President, he served as Associate Director of the Molecular Cardiology Research Laboratories at THI and Associate Director of Drug Discovery at Encysive Pharmaceuticals. He was awarded his Ph.D. from the University of Texas MD Anderson Cancer Center’s Department of Immunology and was a post-doctoral fellow at The Scripps Research Institute.

He has authored numerous publications, served on Editorial Review Boards, and currently chairs the NIH Innovative Immunology Study Section.

See Publications

Texas Heart Institute Positions

Interests

Education

  • Undergraduate:

    Queen's University at Kingston

  • Postgraduate:

    University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences

  • Fellowships:

    The Scripps Research Institute

Honors, Awards and Memberships

Publications

Pogostin, B. H., Yu, M. H., Azares, A. R. et al. (2022). Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity. Biomater Sci. https://doi.org/10.1039/d2bm01242a.
Hickman, A., Koetsier, J., Kurtanich, T. et al. (2022). LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. J Clin Invest 132, e154152. https://doi.org/10.1172/JCI154152.
Lokugamage, N., Chowdhury, I. H., Biediger, R. J. et al. (2021). Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. NPJ Vaccines 6, 114. https://doi.org/10.1038/s41541-021-00378-5.
Lopez-Silva, T. L., Leach, D. G., Azares, A. et al. (2020). Chemical functionality of multidomain peptide hydrogels governs early host immune response. Biomaterials 231, 119667. https://doi.org/10.1016/j.biomaterials.2019.119667.
Bakthavatsalam, D., Craft, J. W., Kazansky, A. et al. (2020). Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk. Front Immunol 11, 575085. https://doi.org/10.3389/fimmu.2020.575085.
Woodside, D. G. (2019). Nanoparticle imaging of vascular inflammation and remodeling in atherosclerotic disease. Current Cardiovascular Imaging Reports 12. https://doi.org/10.1007/s12410-019-9501-9.
Woodside, D. G., Tanifum, E. A., Ghaghada, K. B. et al. (2018). Magnetic resonance imaging of atherosclerotic plaque at clinically relevant field strengths (1T) by targeting the integrin α4β1. Sci Rep 8, 3733. https://doi.org/10.1038/s41598-018-21893-x.
Kumar, V. A., Liu, Q., Wickremasinghe, N. C. et al. (2016). Treatment of hind limb ischemia using angiogenic peptide nanofibers. Biomaterials 98, 113–119. https://doi.org/10.1016/j.biomaterials.2016.04.032.
Deng, Y., Yang, Z., Terry, T. et al. (2016). Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia. Nat Commun 7, 11276. https://doi.org/10.1038/ncomms11276.
Bakthavatsalam, D., Soung, R. H., Tweardy, D. J. et al. (2014). Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor. FEBS Lett 588, 2133–2140. https://doi.org/10.1016/j.febslet.2014.04.049.

Recent News

See All

The Texas Heart Institute Names Dr. Yaxin Wang as First Female Endowed Chair for Innovative Device & Engineering Applications

The Texas Heart Institute is proud to announce Yaxin Wang, PhD, as the John S. Dunn Endowed Chair in Innovative...

Read more

Research Social Delivers Dynamic Afternoon Focused on Collaborative Science

On November 20, 2024, The Texas Heart Institute (THI) held its first-ever Research Social, marking a significant shift from traditional...

Read more

7 Hills Pharma Announces First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors

The Texas Heart Institute is excited to share the groundbreaking progress of 7 Hills Pharma Inc. (“7 Hills”), a clinical-stage...

Read more